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Diagnostic Surgical Pathology: the importance of Second
Opinion in a Developing Country
Z. Ahmed,N. Yaqoob,S.Muzaffar,N. Kayani  ( Department of Pathology and Microbiology. The Aga Khan
University Hospipital, Karachi ) 




To review the cases sent  to the section of histopathology,  Aga Khan Universty (AKU) for  second
opinion and see whether there are significant  differences in  the original outside diagnosis and  the
subsequent diagnosis submitted by us. 
Methods:
A retrospective study of all consecutive cases for second opinion in the form of paraffin blocks from
1st Novemver 2001 to 31st July 2002. The primary submitted diagnosis in each case was compared
with the subsequent AKU diagnosis. 
Results: 
The  study included a  total of 381 cases.  However,  in  45 cases  (11.81%),  initial  histopathological
diagnosis  was  not  provided.  Out  of the  remaining  336  cases,  there  were  differences  between the
original diagnosis and the subsequent AKU diagnosis in 120 cases (35.71%). Out of these 120 cases,
immunohistochemistry was performed in 65 cases (54.16%) only.
Conclusion: 
In a  developing country like Pakistan,  where few laboratories  are equipped to  function as modern
histopathology units, second opinion on difficult  cases is  very important. Worldwide, the concept of
second opinion in surgical pathology is well established (JPMA 54:306;2004).
Introduction 
While the basic aim of the practice of surgical pathology is to provide accurate diagnosis, it is equally
essential to prevent  an erroneous diagnosis,  which can result  in  serious errors in  the treatment  and
prognosis of the patient. In Pakistan, surgical pathology is still evolving as a science and it is only now
that clinicians are becoming aware of the importance of an accurate surgical pathology diagnosis for
the treatment  of their  patients.  In a  developing  country like Pakistan where most  centers lack  the
facilities and expertise that are needed to function as modern surgical pathology units, the Section of
Histopathology  at  the  Aga  Khan  University  Hospital  is  serving  as  the  major  referral  center  for
diagnostic surgical pathology. While the overwhelming majority of surgical pathology cases which we
report are those which are sent primarily to us, a new trend is being observed which is represented by
cases that are sent to us for second opinion by clinicians and in some cases by the primary pathologists
themselves.  The purpose of this study is to review the cases sent to Section of Histopathology, Aga
Khan University for second opinion and see whether there are significant differences in the original
outside diagnosis and the subsequent diagnosis submitted by us. 
Materials and Methods 
 All consecutive cases for second opinion in the form of paraffin blocks, which were received over a
nine-month period i.e., from 1st November 2001 to 31st July 2002, were included in the study. The
primary submitted diagnosis in each case was compared with the diagnosis submitted by us. The use of
immunohistochemistry in 54.16% cases was noted. It was assumed that the blocks we received for
second opinion were the same ones on which the original diagnosis was submitted. 
Results 
 Over the 9 month study period, a total of 381 cases were received for second opinion. In 336 cases
(88.18%), the initial surgical pathology diagnosis was provided. In 45 cases (11.81%) initial surgical
pathology diagnosis was not provided. In 204 out of 336 cases (60.71%) initial diagnosis 
Table1. Commonest organ systems on which second opintion was sougt. 
1 Lymph Nodes 72 21.42
2 Soft Tissues 65 19.34
3 GIT* 52 15.47
4 Bones and Joints 30 8.92
5 Breast 30 8.92
6 Female genital tract** 27 8.03
7 Head and Neck*** 27 8.03
* Includes liver, gall bladder andbiliary tract, pancreas, and salivary glands. ** Includes vulva, vagina,
cervix, endometrium, ovaries, and placenta. *** Includes jaws and oral cavity, nose, paranasal sinuses,
nasopharynx, larynx, eyes and ocular adnexae. 
Table2. Lymph nodes cases. 
S.
No. Submitted Diagnosis Second opinion Diagnosis 
1 Chornic granulomatous inflammation with
caseation necrosis. T.B 
Peripheral T cell NHL (LCA, T positive) 
2 Non Hodgin's Lymphoma Reactive folicular Huperplasia. 
3 Chornic granulmatous inflammation T.B. Reactive lymphadenitis not T.B. nonspecific 
4 Hodgkin's lymphoma mixed cellularity Anaplastic large cell (kil) lymphoma 
5 Non Hodgkin's lymphoma Chronic Granulomatous inflammation T.B. 
6 Non Hodgkin's lymphoma Reactive lumphadenitis 
7 D/DT cell NHL/Hodgkin's disease Diffuse large cell NHL of B phenotype (LCA,
B positive) 
8 Hodgkin's lymphoma mixed cellularity Diffuse large cell NHL of B phenotype (LCA,
B positive) 
9 Metastatic Carcinoma Diffuse large cell NHL of B phenotype (LCA,
B positive) 
10 Hodgkin's lymphoma Atypical lymphoid hyperplasia 
11 Non Hodgkin's lymphoma Non-specific reactive lymphadenitis 
12 Follicular lymphoma Reactive folicular hyperplasia 
13 Reactive lymphadenitis Diffuse large cell NHL of B phenotype (LCA,
B positive) 
14 D/D reactive lymphadenties Hodgkin's
lymphoma 
Diffuse large cell NHL of B phenotype (LCA,
B positive) 
15 Hodgkin's lymphoma Non-specific reactive lymphadenitis 
16 Non Hodgkin's lymphoma Reactive follicular hyperplasia 
17 Follicular lymphoma Reactive follicular hyperplasia 
18 Non Hodgkin's lymphoma Reactive follicular hyperplasia 
19 Chronic granulomatous inflammation T.B Atypical lymphoid hyperplasia 
20 Malignant undifferentiated neoplasm Chronic granulomatous inflammation T.B 
21 Non Hodgkin's lymhoma Metastatic carcinoma (CK MNF, CAM 5.2
positive LCA negative) 
22 Reactive lymhadenitis Diffuse large cell NHL of B phenotype (LCA,
B positive) 
and AKU diagnosis were the same. In 120 cases (35.71%), AKU diagnosis was different from the
initial diagnosis. In 12 cases, we could not give a diagnosis due to the presence of marked
fixation/processing artifact. Immunohistochemistry was performed in 125 out of 336 cases (37.20%).
Out of the 120 cases in which the initial diagnosis and AKU diagnosis were different,
Immunohistochemistry was performed in 65 cases (54.16%). Table 1 lists the commonest organ
systems on which second opinion was sought, while tables 2 to 10 list the cases with differences in
diagnosis belonging to various organ systems. 
Discussion 
The Section of Histopathology at the Aga Khan University Hospital, Karachi is the largest center of
histopathology in Pakistan. In 2001, over 28,000 cases of surgical pathology and over 14,000 cases of
cytopathology were reported. The section has the services of six full time academic pathologists with
diverse background along with ten to  twelve  fellows and  residents.  The section acts as  the major
referral center for histopathology in the country and specimens for primary diagnosis as well as second
opinion are received from all over the country through laboratory collection points of the Aga Khan
University Hospital located in all important cities and towns of the country. The section is equipped
with the latest state of the art Immunohistochemistry and Molecular labs, and is playing a leading role
in the development  and advancement  of diagnostic  histopathology in  the country.  Pakistan being a
developing country, there are very few laboratories, which can function as modern surgical pathology
units. Facilities like Immunohistochemistry are restricted to a handful of centers in the entire country.
Moreover,  clinicians,  especially  in  small  towns  and  cities  are  only  now  becoming  aware  of  the
importance of an accurate surgical pathology diagnosis. With this increased awareness and recognition
of surgical pathology as a major science, sensitivities of clinicians towards surgical pathology diagnosis
are also increasing and more and more cases are being received by us in which a second opinion is
sought. 
Table3. Soft tissue eases. 
S. No. Submitted dianosis Second opinion diagnosis 
1 Fumngal linfection Neurofiborma (S 100 protein positive) 
2 Soft Tissue sarcoma Diffiuse large cell NHL of B cell phenotype (LCA panB positive) 
3 Mailgnant peripheral nerve sheathtumor 
Metastatic carcinorma (CK MNF and CAM 5.2
positive) 
4 lipsarcoma Malignant peripheral nerve sheath tumor, (Vimentin S100 protein positive) 
5 Lipoma Ewing's sarcoma/ PNET (Vimentin, MIC 2 positive) 
6 Hemangiopericytoma Fibrosarcoma 
7 Fibrosarcoma Leiomyosarcoma (Vimentin, ASMA, Desmin positive) 
8 Fibrosarcoma Leiomyoma ( Vimentin, ASMA positive) 
9 Fibrosarcoma Synovial sarcoma (CK MNF, CAM 5.2 EMA,Vimentin positive) 
10 Malignant peripheral Nerve sheathtumor 
Malignant Melanoma, (Vimentin, S100 protein, HMB
45 positive) 
11 Small roung blue cell tumor DVDPNET/ Neuroblastoma NHL, (LCA pan B positive) 
12 Myxoid liposarcoma Malignant peripheral nerve sheath tumor (Vimentin,S100 protein positive) 
13 Liposarcoma Malignant peripheral nerve sheath tumor (Vimentin,S100 protein positive) 
14 Non Hodgkin's Lymphoma Yolk Sac Tumor (CK MNF CAM 5.2, AFP positive) 
15 Fibrosarcoma Malignant peripheral nerve sheath tumor high grade(Vimentin, S100 protein positive) 
16 Fibrosarcoma Synovial sarcoma (CK MNF CAM 5.2, EMA,Vimentin positive) 
17 Alveolar soft part sarcoma Malignant Melanoma (Vimentin, ASMA positive) 
18 Pleomorphic liposarcoma Leiomyosarcoma, (Vimentin, ASMA positive) 
20 Angiosarcoma Diffuse large cell NHL of B phenotype (LCA, Bpositive) 
21 Fibrosarcoma Nodular fascitis 
22 Malignant Melanoma Nodular Tenosynow itis 
23 Rhabdomysarcoma Ewing' sarcoma/PNET (MIC 2 positive desmin
negative) 
24 Fibroma Fibrosarcoma Grade II 
25 Tuberculosis Pilomatrixoma 
26 Myxoid liposarcoma Benign Adipose tissue 
27 Metastatic amelanotic melanoma Metastatic carcinoma CK MNF, AE 1 / AE3 positive 
28 Angiosarcoma Benign Fibrous histiocytoma (Vimentin, CD 68positive) 
29 Soft wissue sarcoma Malignant melanoma (Vimentin, S100 protein, HMB45 positive) 
The concept of second opinion in surgical pathology is well established. The American Society of
Clinical Pathologists (ASCP) has recognized second opinion as an important component of total quality
assurance programs in diagnostic surgical pathology and cytopathology.1 The Association of Directors
of Anatomic and Surgical Pathology has developed recommendations for consultations in surgical
pathology.2 Numerous studies in literature have noted the usefulness and efficacy of second opinions in
diagnostic surgical pathology.3-7 An analysis of our results shows that in 35.71% cases, the second
opinion diagnosis submitted by us was different from the original submitted diagnosis. This is a
significantly high figure. The results also show that the differences in diagnosis in most cases were
major, having significant implications for the treatment and prognosis of the patient. It must always be
kept in mind, however, that a difference between primary and secondary diagnosis does not prove that
the latter is correct and studies in literature have demonstrated that diagnostic disagreements occur
between experts. 8 There is a great variation in the results from different studies looking at second
opinions in diagnostic surgical pathology. Krontz et al.5 reported a 1.4% discrepancy rate for all organ
systems while Abt et al.3 reported a 1.3% overall discrepancy rate. These are very low discrepancy
rates. However, Malhotra et al .7 reported a discrepancy rate 
Table 4. Gastrointestinal tract cases. 
S. No. Submitted Diagnosis Second opinion Diagnosis 
1 Esophagus Squamous cell carcinoma Esophagus: mild non specific inflammation 
2 Chronic hepatitis with cholestasis Liver: Hemosiderosis 
3 Pancreas: extra-rena wilm's tumor Pancreas papillary-solid epithelial tumor (Vimentin,NSE, Chromogranin positive) 
4 Liver: liver tumor not further specified Liver: vascular malformation 
5 Liver Teratoma Liver: hemangiondothelioma, (Vimentin, CD31positive) 
6 Rectum: Ganglion cells not seen Rectum ganglion cells seen 
7 Small intestine: Non Hodkin's lymhoma(Immunoblastic) 
Small intestinal inflammatory infectious process
(Typhoid, Yersinia etc) 
8 Gall bladder: Adencorcinoma Gall bladder: Xanthogranulomatous cholecystitis. 
9 Liver: reactive fibrosis Liver: Metasatic adencarcinoma lung possible site ofprimary (CK AE1/AE, CAM 5.2 and CK positive) 
10 Gall bladder: Adencorcinoma Gall bladder: Xanthogranulamatous cholecystits. 
11 Colon: ulcerative colitis with dysplasia,grade II (moderate) 
Non specific inflammationno dysplasia 
12 Stomach: undifferentiated malignanttumor Stomach: Benign gastric tissue 
13 Colon: Adenocarcinoma Colon: non specific inflammation and granulationtissue formation 
14 Partid: Adenoid cystic carcinoma Parotid mucoepidermoid carcinoma, low grade. 
15 Small Intestine: diffuse large cell nonHodgkin's lymphoma 
Small intestine: Burkitt's lymphoma, (LCA, B
positive) 
16 Small intestine ki1 or Hodgkin'slymphoma 
Small intestine T cell Non Hodgkin's lymphoma
(LCA, Pan T positive, Ki 1 negative) 
17 Jejunum: Fibroma Jejunum: Neurofibroma, (Vimentin, S100 positive) 
Table 5. Skin cases. 
S. No. Submitted Diagnosis Second Opinion Diagnosis 
1 Malignant Melanoma Compound Melanocytic nevus 
2 Squamous cell carcinoma Basal Cell Carcinoma 
3 Squamous cell carcinoma Bowen's Disease 
4 Malignant Melanoma Angiosarcoma (CD 31, Ulex Europeus, vimentin positiv, HMB45 ngative) 
5 Kaposi, Sarcoma Lobular capillary Hemangioma 
6 Rperipheral T cell lymphoma Anaplastic large cell (kil 1) lymphoma (Ki 1 positive) 
7 Non Hodgkin's Lymphoma T cell pseudolyphoma 
of 11.6% among 275 cases. Our overall discrepancy rate was very high 35.71% among 336 cases
(results). Various western studies have however, reported high discrepancy rates for specific organ
systems. Harris et al. 9 reported a 24% discrepancy rate for bone and soft tissue sarcomas. Our study
showed 36.66% discrepancy rate for bone and joint cases (results). However, these include both
neoplastic and non neoplastic cases. Jacques et al. 10,11 reported a 23.6% discrepancy rate for
endometrial biopsies. Our study showed an 18.51%discrepancy rate for all female genital tract cases
(results) and as shown in table 8, 4 out of 5 cases were ovarian in origin Epstein et al.12 reported a
9.1% discrepancy rate for prostatic biopsies. Our study showed a 38.46% discrepancy rate for all male
genital tract cases (results) and as shown in Table 9, 4 out of 5 cases were prostatic in origin. Kim et
al.13 reported a 16.7% and 27.3% discrepancy rate for Hodgkin's and non-Hodgkin's lymphomas
respectively. Our study showed a 30.55% discrepancy rate for lymph node cases, both neoplastic and
non neoplastic (results). Bruner et al.14 reported an 8.8% discrepancy rate for 
Table 7. Head and neck cases. 
S.
No. Submitted diagnosis Second opinion diagnosis 
1  Nose Liposarcoma Malignant Melanoma (Vimentin, S100ProteinHMB 45positive) 
2 Nasopharynx: Nasopharyngeal carcinoma Large cell NHL of B phenotype (LCA, B positive)
3 Hard Palate sarcoma Diffuse large cell NHL of B phenotype (LCA, Bpositive) 
4 Cheek: Non Hodgkin's lymphoma Neuroblastoma ( NSE, S100 protein positive,LCA negative) 
5 Ehomoid Sinus Chronic granulomatousinflammation T.B No fungus seen. 
Chronic granulomatous inflammation fungus
positive no T.B 
6 Nose: Plasmacytoma Peripheral T cell Non Hodgkin's lymphuma(PTCL)(LCA, T positive) 
7 Nose malignant neoplasm D/D carcinoma/NHL 
Malignant Melanoma, (Vimentin, S100 protein,
HMB 45 positive) 
8 Parapharyngeal area: Heman giopericytoma  Solitary fibrous tumor (Vimentin, CD 34 positive)
9 Ethmoid Sinus: Malignant neoplasm D/D
rhabdomyosarcoma 
poorly differentiated Carcinoma, (CK MNF, CK
CAM 5.2 positive) 
10 Vocal cord: Carcinoma Inflammatory pseudotumor (Vimentin, ASMApositive cytokeratins negative) 
11 Cheek Carcinoma Diffuse large cell non Hodgkin's lymphoma of Bphenotype, LCA B positive) 
12 Oral cavity: poorly differentiated carcinoma Diffuse large cell Non Hodgkin's lymphoma of Bphenotype (LCA, B positive) 
Table 8. Female genital tract cases. 
 
S.No. Submitted diagnosis Second opinion diagnosis 
1 Cervix Dysplasia Sqyamous metaplasia and non-specific inflammation Nodysplasia 
2 Overy: Bordeline serous tumor Endometriotic Cyst 
3 Overy: Sertoli leydig cell tumor Gramulosa cell tumor, (Vimentin, ASMA, S100 protein,MIC 2 positive) 
4 Overy: Malignant tumor Benign ovarian tissue 
5 Ovary: poorly differentiated
carvinoma Dysgerminoma 
Table 9 Male genital tract cases. 
S.No. Submitted diagnosis Second opinion diagnosis 
1 Prostate: Adenocarvinoma Atypical adenomatous hyperplasia 
2 Prostate: Adenocarvinoma Rhabdomysosarcoma. (Vementin, Desmin pisitive Keratins
negative) 
3 Prostate: Adenocarvinoma Transitional cell carcinoma (PSA negative) 
4 Testis: Seminoma Benign testicular tissue 
5 Prostate: sqyamous cell carcinoma Infarction with squamous metaplasia 
Table 10. Miscellaneous cases with difference in diagnosis. 
S.No. Submitted diagnosis Second opinion diagnosis 
1 Lung: Pulmonary blastoma Orfanizing pneumoia 
2 Glomus Jugulare: Glomus Jugularetumor 
Choroid plexus papilloma (Kerains, EMA pisitive)
3 Breast: Mammary dysplasia Severe chronic non-specific inflammation and fat necrosis 
4 Breast: Mammary dysplasia ProstateAdenocarcinoma (PSA positive)
5 Urinary bladder: Transitional cell
carcinoma, grade III 
prostate Adenocarcinoma (PSA positive)
6 Pleura: malignant mesothelioma Reactive mesothelial cells 
7 Thyroid: Follicular carcinoma Papillary carcinoma 
8 Thyroid: Papillary carcinoma Medullary carcinoma (CK MNF, CK, CAM 5.2,S100protein NSE, chromofranin pisitice Thyroglobin negative)
9 Kidney: soindle cell carcinoma Leiomyosarcoma, (Vimentin, ASMA positive: cytokeratins
negative) 
10 Breast infiltrating ductal carcinoma Fibrocystic disease
11 Kidney: Renal cell carcinoma Xanthogranulomatous pyelonephritis 
12 Brain:DesmoplasticMedulloblastoma 
Neuroblastoma, (GFAP, NSE, Chromgranin positive)
neuropathology cases. In our study, neuropathology cases for second opinion were very few except for
one case (Table 10). Our study also showed high discrepancy rates of 53.84%, 44.44% and 32.69% for
skin, head and neck (excluding neuropathology) and gastrointestinal tract cases (results). Malhotra et
al.7 reported a 7% discrepancy rate in skin cases. As shown in Table 10, significant diagnostic
differences were also seen in breast and thyroid cases. It was concluded from the study that a second
opinion for determining a diagnosis of difficult cases by histopathology examination, is highly
recommended. This practice is implemented worldwide 
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